GlassScriptPhysician profile
Armin Miresmaili
NPI 1447844576
$3,726.77
in general payments reported to CMS, 2019-2025
7 companies · $637 in 2025
The $637 reported for 2025 was more than what 84% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $200 · 2022: $1,230 · 2023: $214 · 2024: $1,447 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,904 · Gift: $268 · Consulting Fee: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,903.93 |
| Gift | $268.37 |
| Consulting Fee | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $3,054.96 | 2022-2025 | Invisalign, Vivera Retainers, Invisalign System - Moderate |
| Ortho Organizers, INC. | $199.71 | 2021 | |
| American Orthodontics Corporation | $169.08 | 2022-2025 | Radiance, Empower-Ceramic, LP and Ifit Tubes |
| Lightforce Orthodontics, INC. | $114.37 | 2024-2025 | |
| Envista Holdings Corporation | $76.58 | 2024 | Damon |
| Ormco Corporation | $56.04 | 2023 | Spark |
| Nobel Biocare USA | $56.03 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armin Miresmaili listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.